Chapter 32
Bioresorbable-polymer Everolimus-eluting Stents
Vikas Thondapu,
Nigel Sutherland,
Tom Ford, Bimmer Claessen,
George D. Dangas,
Peter Barlis,
Vikas Thondapu
Search for more papers by this authorNigel Sutherland
Search for more papers by this authorBimmer Claessen
Search for more papers by this authorGeorge D. Dangas
Search for more papers by this authorPeter Barlis
Search for more papers by this authorVikas Thondapu,
Nigel Sutherland,
Tom Ford, Bimmer Claessen,
George D. Dangas,
Peter Barlis,
Vikas Thondapu
Search for more papers by this authorNigel Sutherland
Search for more papers by this authorBimmer Claessen
Search for more papers by this authorGeorge D. Dangas
Search for more papers by this authorPeter Barlis
Search for more papers by this authorBook Editor(s):George D. Dangas MD, MACC, MSCAI, FAHA, FESC,
Carlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC,
Holger Thiele MD,
Peter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP,
Tayo Addo MD, Bimmer Claessen MD, Christian Hengstenberg MD, Nicholas Kipshidze MD,
George D. Dangas MD, MACC, MSCAI, FAHA, FESC
Professor of Medicine (Cardiology) & Surgery (Vascular) Professor of Cardiology Adjunct Professor of Internal Medicine
Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, USA
National Kapodistrian University of Athens, Greece
Medical University of Vienna, Austria
Search for more papers by this authorCarlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC
Professor of Cardiology Director of the Structural Interventional Cardiology Division Honorary Consultant
University of Florence
University Hospital Careggi, Florence, Italy
Cardiologist Royal Brompton Hospital, London, UK
Search for more papers by this authorHolger Thiele MD
Professor of Cardiology at University of Leipzig
Heart Center Leipzig at University of Leipzig, Leipzig, Germany
Search for more papers by this authorPeter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP
Professor of Cardiology Interventional Cardiologist
University of Melbourne, Melbourne, Victoria, Australia
St Vincent's & Northern Hospitals Victoria, Australia
Search for more papers by this authorFirst published: 06 May 2022
Summary
Coronary artery disease is a leading cause of morbidity and mortality, with medical therapy and percutaneous coronary intervention forming the cornerstone of management. Early concerns over first and second generation stents have been overcome with device iterations. Platinum-chromium EES have mature clinical data and along with the cobalt-chromium EES are contemporary gold standard in the drug eluting stent field. Bioresorbable polymer stents may facilitate vessel healing by reducing polymer associated adverse events with stents such as the SYNERGY, holding promise with comparable benchmark DES in early studies with low rates of target vessel failure, target lesion revascularisation and stent thrombosis.
References
- Fischman DL , Leon MB , Baim DS , et al . A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease . N Engl J Med. 1994 ; 331 ( 8 ): 496 – 501 .
-
Grüntzig A
.
TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS
.
The Lancet.
1978
;
311
(
8058
):
263
.
10.1016/S0140-6736(78)90500-7 Google Scholar
- Serruys PW , de Jaegere P , Kiemeneij F , et al . A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease . N Engl J Med. 1994 ; 331 ( 8 ): 489 – 95 .
- Dangas GD , Serruys PW , Kereiakes DJ , et al . Meta-analysis of everolimus-eluting vs paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) . JACC Cardiovasc Interv. 2013 ; 6 ( 9 ): 914 – 22 .
- Gada H , Kirtane AJ , Newman W , et al . 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions) . JACC Cardiovasc Interv . 2013 ; 6 ( 12 ): 1263 – 6 .
- Kirtane AJ , Leon MB , Ball MW , et al . The “final” 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent . JACC Cardiovasc Interv. 2013 ; 6 ( 4 ): 325 – 33 .
- Tada T , Byrne RA , Simunovic I , et al . Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients . JACC Cardiovasc Interv. 2013 ; 6 ( 12 ): 1267 – 74 .
- Serruys PW , Farooq V , Kalesan B , et al . Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents vs durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Vs ERodable Stent Coating) randomized, noninferiority trial . JACC Cardiovasc Interv. 2013 ; 6 ( 8 ): 777 – 89 .
- Briguori C , Sarais C , Pagnotta P , et al . In-stent restenosis in small coronary arteries: impact of strut thickness . J Am Coll Cardiol. 2002 ; 40 ( 3 ): 403 – 9 .
- Craig CH , Friend CM , Edwards MR , et al . Mechanical properties and microstructure of platinum enhanced radiopaque stainless steel (PERSS) alloys . Journal of Alloys and Compounds. 2003 ; 361 ( 1 ): 187 – 99 .
- Menown IB , Noad R , Garcia EJ , Meredith I . The platinum chromium element stent platform: from alloy, to design, to clinical practice . Adv Ther. 2010 ; 27 ( 3 ): 129 – 41 .
- O'Brien BJ , Stinson JS , Larsen SR , et al . A platinum–chromium steel for cardiovascular stents . Biomaterials . 2010 ; 31 ( 14 ): 3755 – 61 .
- Bennett J , Dubois C . A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease . Biologics. 2013 ; 7 : 149 – 59 .
- Ota T , Ishii H , Sumi T , et al . Impact of coronary stent designs on acute stent recoil . J Cardiol. 2014 ; 64 ( 5 ): 347 – 52 .
- Gutensohn K , Beythien C , Bau J , et al . in vitro Analyses of Diamond-like Carbon Coated Stents: Reduction of Metal Ion Release, Platelet Activation, and Thrombogenicity . Thrombosis Research. 2000 ; 99 ( 6 ): 577 – 85 .
- Köster R , Vieluf D , Kiehn M , et al . Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis . The Lancet. 2000 ; 356 ( 9245 ): 1895 – 7 .
-
Ruygrok P
,
Serruys P
.
Intracoronary stenting. From concept to custom
.
Circulation.
1996
;
945
:
882
–
90
.
10.1161/01.CIR.94.5.882 Google Scholar
- Chen Q , Thouas GA . Metallic implant biomaterials . Materials Science and Engineering: R: Reports. 2015 ; 87 : 1 – 57 .
- Chiu TH , Nyilas E , Lederman DM . Thermodynamics of native protein/foreign surface interactions. IV. Calorimetric and microelectrophoretic study of human fibrinogen sorption onto glass and LTI-carbon . Trans Am Soc Artif Intern Organs. 1976 ; 22 : 498 – 513 .
- de Mel A , Cousins BG , Seifalian AM . Surface Modification of Biomaterials: A Quest for Blood Compatibility . International Journal of Biomaterials. 2012 ; 2012 : 707863 .
- Fang F , Satulovsky J , Szleifer I . Kinetics of Protein Adsorption and Desorption on Surfaces with Grafted Polymers . Biophysical Journal. 2005 ; 89 ( 3 ): 1516 – 33 .
- Fang F , Szleifer I . Kinetics and Thermodynamics of Protein Adsorption: A Generalized Molecular Theoretical Approach . Biophysical Journal. 2001 ; 80 ( 6 ): 2568 – 89 .
- Hoffman AS . Modification of material surfaces to affect how they interact with blood . Ann N Y Acad Sci. 1987 ; 516 : 96 – 101 .
- Huck V , Schneider MF , Gorzelanny C , Schneider SW . The various states of von Willebrand factor and their function in physiology and pathophysiology . Thromb Haemost. 2014 ; 111 ( 4 ): 598 – 609 .
- Sawyer PN , Srinivasan S . The role of electrochemical surface properties in thrombosis at vascular interfaces: cumulative experience of studies in animals and man . Bull N Y Acad Med. 1972 ; 48 ( 2 ): 235 – 56 .
- Srokowski E , Woodhouse K . Evaluation of the bulk platelet response and fibrinogen interaction to elastin-like polypeptide coatings . J Biomed Mater Res. Part A. 2014 ; 102 .
- Tanaka M , Motomura T , Kawada M , et al . Blood compatible aspects of poly(2–methoxyethylacrylate) (PMEA)--relationship between protein adsorption and platelet adhesion on PMEA surface . Biomaterials. 2000 ; 21 ( 14 ): 1471 – 81 .
- Tokuda K , Ogino T , Kotera M , Nishino T . Simple method for lowering poly(methyl methacrylate) surface energy with fluorination . Polymer Journal. 2015 ; 47 ( 1 ): 66 – 70 .
- Vroman L , Adams AL . Identification of rapid changes at plasma–solid interfaces . J Biomed Mater Res. 1969 ; 3 ( 1 ): 43 – 67 .
- Gray JJ . The interaction of proteins with solid surfaces . Curr Opin Struct Biol. 2004 ; 14 ( 1 ): 110 – 5 .
- Eppihimer Michael J , Sushkova N , Grimsby Jessica L , et al . Impact of Stent Surface on Thrombogenicity and Vascular Healing . Circulation: Cardiovascular Interventions. 2013 ; 6 ( 4 ): 370 – 7 .
- Soucy NV , Feygin JM , Tunstall R , et al . Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating . EuroIntervention. 2010 ; 6 ( 5 ): 630 – 7 .
- Wilson GJ , Huibregtse BA , Stejskal EA , et al . Vascular response to a third generation everolimus-eluting stent . EuroIntervention. 2010 ; 6 ( 4 ): 512 – 9 .
- Wang JC , Carrié D , Masotti M , et al . Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent . Cardiovasc Revasc Med. 2015 ; 16 ( 2 ): 65 – 9 .
- Kastrati A , Mehilli J , Dirschinger J , et al . Restenosis after coronary placement of various stent types . Am J Cardiol. 2001 ; 87 ( 1 ): 34 – 9 .
- Sketch MH , Jr. , Ball M , Rutherford B , et al . Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system . Am J Cardiol. 2005 ; 95 ( 1 ): 8 – 12 .
- Mamas AM , Paul DW . Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database . EuroIntervention. 2012 ; 8 ( 2 ): 196 – 204 .
- Park KW , Kang SH , Kang HJ , et al . A randomized comparison of platinum chromium-based everolimus-eluting stents vs cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial . J Am Coll Cardiol. 2014 ; 63 ( 25 Pt A ): 2805 – 16 .
- Hanratty CG , Walsh SJ . Longitudinal compression: a “new” complication with modern coronary stent platforms--time to think beyond deliverability? EuroIntervention. 2011 ; 7 ( 7 ): 872 – 7 .
- Leibundgut G , Gick M , Toma A , et al . Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort . Catheter Cardiovasc Interv. 2013 ; 81 ( 5 ): E206 – 14 .
- Abdel-Wahab M , Sulimov DS , Kassner G , et al . Longitudinal deformation of contemporary coronary stents: an integrated analysis of clinical experience and observations from the bench . J Interv Cardiol. 2012 ; 25 ( 6 ): 576 – 85 .
- Dvir D , Kitabata H , Barbash IM , et al . in vivo evaluation of axial integrity of coronary stents using intravascular ultrasound: Insights on longitudinal stent deformation . Catheter Cardiovasc Interv. 2014 ; 84 ( 3 ): 397 – 405 .
- von Birgelen C , Sen H , Lam MK , et al . Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial . The Lancet. 2014 ; 383 ( 9915 ): 413 – 23 .
- Williams PD , Mamas MA , Morgan KP , et al . Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms . EuroIntervention. 2012 ; 8 ( 2 ): 267 – 74 .
- Shinji I , Gary SM , Kyeong Ho Y , et al . Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study . EuroIntervention. 2014 ; 9 ( 11 ): 1301 – 8 .
- Kereiakes DJ , Popma JJ , Cannon LA , et al . Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials . EuroIntervention. 2012 ; 8 ( 2 ): 187 – 95 .
- Lupi A , Porto I , Rognoni A , et al . Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry . J Invasive Cardiol. 2014 ; 26 ( 7 ): 311 – 7 .
- Ormiston JA , Webber B , Ubod B , et al . Stent longitudinal strength assessed using point compression: insights from a second-generation, clinically related bench test . Circ Cardiovasc Interv. 2014 ; 7 ( 1 ): 62 – 9 .
- Ormiston JA , Webber B , Webster MW . Stent longitudinal integrity bench insights into a clinical problem . JACC Cardiovasc Interv. 2011 ; 4 ( 12 ): 1310 – 7 .
- Santosh P , Tanya S , Tamer M , et al . Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents . EuroIntervention. 2012 ; 8 ( 2 ): 275 – 81 .
- Sarno G , Lagerqvist B , Fröbert O , et al . Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR) . Eur Heart J. 2012 ; 33 ( 5 ): 606 – 13 .
- Sarno G , Lagerqvist B , Nilsson J , et al . Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR . J Am Coll Cardiol. 2014 ; 64 ( 1 ): 16 – 24 .
- Verheye S , Martinet W , Kockx MM , et al . Selective clearance of macrophages in atherosclerotic plaques by autophagy . J Am Coll Cardiol. 2007 ; 49 ( 6 ): 706 – 15 .
- Shreenivas SS , Kereiakes DJ . Evolution of the SYNERGY bioresorbable polymer metallic coronary stent . Future Cardiol. 2018 ; 14 ( 4 ): 307 – 17 .
- Wilson GJ , Huibregtse BA , Pennington DE , Dawkins KD . Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries . EuroIntervention. 2012 ; 8 ( 2 ): 250 – 7 .
- Meredith IT , Verheye S , Dubois CL , et al . Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent . J Am Coll Cardiol. 2012 ; 59 ( 15 ): 1362 – 70 .
- Kereiakes DJ , Meredith IT , Windecker S , et al . Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial . Circ Cardiovasc Interv. 2015 ; 8 ( 4 ).
- Kereiakes DJ , Windecker S , Jobe RL , et al . Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents . Circ Cardiovasc Interv. 2019 ; 12 ( 9 ): e008152 .
- Kereiakes DJ , Meredith IT , Masotti M , et al . Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy . EuroIntervention. 2017 ; 12 ( 16 ): 1987 – 94 .
- Sarno G , Lagerqvist B , Olivecrona G , et al . Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) . Catheter Cardiovasc Interv. 2017 ; 90 ( 6 ): 881 – 7 .
- Varenne O , Cook S , Sideris G , et al . Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial . The Lancet. 2018 ; 391 ( 10115 ): 41 – 50 .
- Han Y , Liu H , Yang Y , et al . A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study . EuroIntervention. 2017 ; 13 ( 10 ): 1210 – 7 .
- Khan AR , Tripathi A , Farid TA , et al . Stent thrombosis with bioabsorbable polymer drug-eluting stents: insights from the Food and Drug Administration database . Coron Artery Dis. 2017 ; 28 ( 7 ): 564 – 9 .
- Zanchin C , Ueki Y , Zanchin T , et al . Everolimus-Eluting Biodegradable Polymer Vs Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical Practice . JACC Cardiovasc Interv. 2019 ; 12 ( 17 ): 1665 – 75 .
- Kereiakes DJ , Granada JF . SYNERGY Early Stent Thrombosis . JACC: Cardiovascular Interventions. 2019 ; 12 ( 21 ): 2227 .
- von Birgelen C , Kok MM , van der Heijden LC , et al . Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents vs durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial . The Lancet. 2016 ; 388 ( 10060 ): 2607 – 17 .
- Maeng M , Christiansen EH , Raungaard B , et al . Everolimus-Eluting Vs Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial) . JACC Cardiovasc Interv. 2019 ; 12 ( 7 ): 624 – 33 .
- Picard F , Pighi M , de Hemptinne Q , et al . Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis . Int J Cardiol. 2019 ; 278 : 51 – 6 .
- Patted SV , Patted AS , Turiya PK , Thakkar AS . Clinical Outcomes of World's Thinnest (50 μmr) Strut Biodegradable Polymer Coated Everolimus-Eluting Coronary Stent System in Real-World Patients . Cardiol Res. 2018 ; 9 ( 6 ): 370 – 7 .
- Aoki J , Kozuma K , Awata M , et al . Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan . Circ J. 2016 ; 80 ( 4 ): 906 – 12 .
